These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28435907)

  • 41. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.
    Caswell DR; Swanton C
    BMC Med; 2017 Jul; 15(1):133. PubMed ID: 28716075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clonal evolution in cancer.
    Greaves M; Maley CC
    Nature; 2012 Jan; 481(7381):306-13. PubMed ID: 22258609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing.
    Jiang Y; Qiu Y; Minn AJ; Zhang NR
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5528-37. PubMed ID: 27573852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LinG3D: visualizing the spatio-temporal dynamics of clonal evolution.
    Hu A; Ojwang' AME; Olumoyin KD; Rejniak KA
    BMC Bioinformatics; 2024 May; 25(1):201. PubMed ID: 38802748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Clonal Evolution Simulator for Planning Somatic Evolution Studies.
    Srivatsa A; Lei H; Schwartz R
    J Comput Biol; 2023 Aug; 30(8):831-847. PubMed ID: 37184853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics.
    Nam AS; Chaligne R; Landau DA
    Nat Rev Genet; 2021 Jan; 22(1):3-18. PubMed ID: 32807900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concepts in solid tumor evolution.
    Sidow A; Spies N
    Trends Genet; 2015 Apr; 31(4):208-14. PubMed ID: 25733351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling stress-induced responses: plasticity in continuous state space and gradual clonal evolution.
    Bukkuri A
    Theory Biosci; 2024 Feb; 143(1):63-77. PubMed ID: 38289469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine.
    Hiley C; de Bruin EC; McGranahan N; Swanton C
    Genome Biol; 2014 Aug; 15(8):453. PubMed ID: 25222836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic and non-genetic clonal diversity in cancer evolution.
    Black JRM; McGranahan N
    Nat Rev Cancer; 2021 Jun; 21(6):379-392. PubMed ID: 33727690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
    Gupta RG; Somer RA
    Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonal cooperativity in heterogenous cancers.
    Zhou H; Neelakantan D; Ford HL
    Semin Cell Dev Biol; 2017 Apr; 64():79-89. PubMed ID: 27582427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computational Methods for Analysis of Tumor Clonality and Evolutionary History.
    Goh G; McGranahan N; Wilson GA
    Methods Mol Biol; 2019; 1878():217-226. PubMed ID: 30378079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Big Bang Tumor Growth and Clonal Evolution.
    Sun R; Hu Z; Curtis C
    Cold Spring Harb Perspect Med; 2018 May; 8(5):. PubMed ID: 28710260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Towards Multidrug Adaptive Therapy.
    West J; You L; Zhang J; Gatenby RA; Brown JS; Newton PK; Anderson ARA
    Cancer Res; 2020 Apr; 80(7):1578-1589. PubMed ID: 31948939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mathematical modeling and computational prediction of cancer drug resistance.
    Sun X; Hu B
    Brief Bioinform; 2018 Nov; 19(6):1382-1399. PubMed ID: 28981626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolutionary scalpels for dissecting tumor ecosystems.
    Rosenbloom DIS; Camara PG; Chu T; Rabadan R
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A population genetics perspective on the determinants of intra-tumor heterogeneity.
    Hu Z; Sun R; Curtis C
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal evolution models of tumor heterogeneity.
    Shlush LI; Hershkovitz D
    Am Soc Clin Oncol Educ Book; 2015; ():e662-5. PubMed ID: 25993239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.